Showing 7341-7350 of 10620 results for "".
- Geographic Disparities in Dementia: Implications for Clinical Practicehttps://reachmd.com/news/geographic-disparities-in-dementia-implications-for-clinical-practice/2475089/Recent population-level data expose stark geographic disparities in the burden of dementia, challenging clinicians to adapt strategies to areas with the highest rates. Geographical differences discovered by UCSF researchers highlight a
- Evolving Role of CT Imaging in Emergency Departments: Trends and Innovationshttps://reachmd.com/news/evolving-role-of-ct-imaging-in-emergency-departments-trends-and-innovations/2475081/As emergency departments confront surging patient volumes and increasingly complex presentations, the demand for CT imaging that delivers both speed and precision has never been greater, reshaping how clinicians approach critical diagnostic p
- Evolving Strategies in Provisional Bifurcation PCIhttps://reachmd.com/news/evolving-strategies-in-provisional-bifurcation-pci/2475080/Evolving strategies in provisional bifurcation percutaneous coronary intervention (PCI) now leverage precise bifurcation angle analysis and adjunctive revascularization techniques to confront the persistent challenge of side branch occlusion.
- Mass Antibiotic Use and Emerging Resistance: Striking the Balancehttps://reachmd.com/news/mass-antibiotic-use-and-emerging-resistance-striking-the-balance/2475082/The widespread use of antibiotics like azithromycin in public health initiatives is reshaping bacterial ecosystems, leading to emerging resistance patterns that challenge current infectious disease management. Frontline clinicians and
- ERs Aren't Ready for Boom in Older Patients with Dementiahttps://reachmd.com/news/ers-arent-ready-for-boom-in-older-patients-with-dementia/2475062/As dementia rates climb, emergency departments face unprecedented challenges in accommodating and effectively treating older patients with cognitive impairment. Now more than ever, ED clinicians contend with a surge in dementia present
- Harnessing M2 Macrophages: New Frontiers in Combating Disc Degenerationhttps://reachmd.com/news/harnessing-m2-macrophages-new-frontiers-in-combating-disc-degeneration/2474998/Intervertebral disc degeneration represents a pervasive and underappreciated driver of chronic back pain, demanding orthopedic surgeons to integrate emerging cellular and molecular mechanisms—particularly the role of M2 macrophages—into evolv
- 2025 SCALE: Temple Filler Is Underappreciated But Crucialhttps://reachmd.com/news/2025-scale-temple-filler-is-underappreciated-but-crucial/2475375/At the 20th anniversary of the Music City Symposium for Cosmetic Advances and Laser Education (SCALE), Vince Bertucci, MD, FRCPC, gave a lecture titled “Temple Fillers: Revisiting Current Dogma.” Key takeaway messages from the lecture included: THE TEMPLE’S ROLE IN
- Emerging Therapies in Hormone Receptor-Positive Breast Cancer: Exploring ESR1 and PIK3CA Mutationshttps://reachmd.com/news/emerging-therapies-in-hormone-receptor-positive-breast-cancer-spotlight-on-esr1-and-pik3ca-mutations/2474996/Emerging therapies targeting ESR1 and PIK3CA mutations are reshaping outcomes for patients with ER+, HER2− advanced breast cancer by overcoming endocrine resistance and extending survival beyond that achieved with standard endocrine regimens.
- New Frontiers in Treating Eosinophilic COPD: Mepolizumab and Ensifentrinehttps://reachmd.com/news/new-frontiers-in-treating-eosinophilic-copd-mepolizumab-and-ensifentrine/2474987/Managing recurrent exacerbations in patients with eosinophilic COPD remains a clinical challenge, as traditional therapies may not always effectively break the cycle of airway inflammation, particularly in patients with higher eosinophil leve
- Advancements and Challenges in Minimally Invasive Esophagectomy for Esophageal Cancerhttps://reachmd.com/news/advancements-and-challenges-in-minimally-invasive-esophagectomy-for-esophageal-cancer/2475025/Thoracic surgeons face the dual challenge of maximizing oncological efficacy while minimizing postoperative morbidity in esophageal cancer, and the Survival Comparison Bet